icon
0%

Medtronic Plc MDT - News Analyzed: 5,499 - Last Week: 100 - Last Month: 400

↑ Medtronic Plc (MDT): A Strong Contender in the Bio-Tech Market Amidst Challenges

Medtronic Plc (MDT): A Strong Contender in the Bio-Tech Market Amidst Challenges
Medtronic Plc (MDT) has been making significant strides recently, securing a place among stocks to invest in for income. Its position has been raised by National Pension Service and entities like SVB Wealth LLC. Fisher Asset Management LLC, and others have also grown their holdings. MDT has been lauded as one of the best medical device stocks to buy. The stock's performance has impressed large institutional owners and even led Jim Cramer to call MDT a winner. However, the company is struggling with potential manufacturing optimization amid tariff threats and a recent slump in stock price. They continue to vye for strong revenue growth and AI-driven innovations, and appear unwavered by higher tariffs. Nevertheless, various investors including QRG Capital Management Inc. and Equitable Trust Co. continue to invest in MDT. Despite a recent Q3 earnings miss, Medtronic still managed to outperform the broader market. Furthermore, the company has recently appointed Thierry PiΓ©ton as CFO and announced a cash dividend. However, the stock has been regarded as undervalued and underperforming. Overall, experts seem optimistic about the future of Medtronic Plc.

Medtronic Plc MDT News Analytics from Mon, 19 Aug 2024 07:00:00 GMT to Sat, 01 Mar 2025 12:34:33 GMT - Rating 7 - Innovation 6 - Information 8 - Rumor -2

The email address you have entered is invalid.